TYROSINE-RESTRICTED AND PHENYLALANINE-RESTRICTED FORMULA DIET AUGMENTS IMMUNOCOMPETENCE IN HEALTHY HUMANS

被引:22
作者
NORRIS, JR
MEADOWS, GG
MASSEY, LK
STARKEY, JR
SYLVESTER, DM
LIU, SY
机构
[1] WASHINGTON STATE UNIV,COLL PHARM,GRAD PROGRAM NUTR,PULLMAN,WA 99164
[2] WASHINGTON STATE UNIV,GRAD PROGRAM TOXICOL,PULLMAN,WA 99164
[3] WASHINGTON STATE UNIV,DEPT FOOD SCI & HUMAN NUTR,PULLMAN,WA 99164
[4] MONTANA STATE UNIV,DEPT MICROBIOL,BOZEMAN,MT 59717
关键词
Immunocompetence; Natural killer cells; Phenylalanine; Platelet aggregation; Tyrosine;
D O I
10.1093/ajcn/51.2.188
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Previous studies indicate that limiting tyrosine and phenylalanine intake in the diet decreases tumor growth and metastasis. General health status, immune status, and platelet function were studied in nine healthy human subjects consuming low-protein foods supplemented with formula diets free of tyrosine and phenylalanine to maintain total daily intake of tyrosine at 2.4 mg/kg body wt and phenylalanine at 3.5 mg/kg body wt. This regimen decreased plasma tyrosine (p < 0.05) but not phenylalanine. Blood indicators of protein status were not changed. Platelet aggretation decreased in response to adenosine diphosphate and platelet activating factor in seven of nine subjects. Natural killer, T-helper, and T-cytotoxic/suppressor lymphocyte numbers proportionally increased relative to neutrophils (p < 0.05). Natural killer cell activity increased in six of nine subjects. Increased natural killer cell activity and decreased platelet aggregation are two indices associated with decreased tumor growth and metastasis.
引用
收藏
页码:188 / 196
页数:9
相关论文
共 51 条
[1]  
ABDALLAH RM, 1987, J NATL CANCER I, V78, P759
[2]   MECHANISM OF ACTION OF PHORBOL-MYRISTATE ACETATE ON HUMAN NATURAL-KILLER CELL-ACTIVITY [J].
ABRAMS, SI ;
BRAY, RA ;
BRAHMI, Z .
CELLULAR IMMUNOLOGY, 1983, 80 (02) :230-240
[4]   AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE AND ITS REVERSAL [J].
BORN, GVR .
NATURE, 1962, 194 (4832) :927-&
[5]  
BOUNOUS G, 1981, CLIN INVEST MED, V4, P109
[6]  
BOUNOUS G, 1978, IMMUNOLOGY, V35, P257
[7]  
BRYANT RW, 1981, SELENIUM BIOL MED, P395
[8]  
CHANDRA S, 1985, NUTR RES, V5, P5693
[9]  
CLAMAN HN, 1972, NEW ENGL J MED, V8, P338
[10]   WARFARIN INHIBITS BOTH PROCOAGULANT ACTIVITY AND METASTATIC CAPACITY OF LEWIS LUNG-CARCINOMA CELLS - ROLE OF VITAMIN-K DEFICIENCY [J].
COLUCCI, M ;
DELAINI, F ;
VITTI, GDB ;
LOCATI, D ;
POGGI, A ;
SEMERARO, N ;
DONATI, MB .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (11) :1689-1691